This content is from: Premium Tiger Cubs Poised to Benefit From This Covid-Related IPO AbCellera, which has developed a treatment for Covid-19, set terms this week for its IPO. By Stephen Taub December 08, 2020
This content is from: Portfolio Buyout Firms Take ‘Surprisingly Long’ to Exit Post-IPO Holdings — All While Raking in Fees Investors in private equity funds would have fared better under faster sell-down strategies, in terms of net and gross returns, a study found. By Christine Idzelis February 01, 2021
This content is from: Premium These Companies Yielded a Big Payday for Viking Global Investors Two IPOs in which the Tiger Cub held sizable stakes surged in price, while another smaller biopharma stake has more than doubled since going public. By Stephen Taub December 14, 2020
This content is from: Premium An Under-the-Radar Hedge Fund Reaps Big IPO Rewards Bihua Chen’s Cormorant Asset Management is scoring big gains from development stage biopharma companies. By Stephen Taub December 17, 2020
This content is from: Premium Why Hedge Funds Love Health Care IPOs In recent months two companies with hedge fund ownership more than doubled, while several others are also up sharply. By Stephen Taub September 22, 2020
This content is from: Premium Tiger Global, Viking, Maverick Eye IPOs Citadel and Farallon are also gearing up for private holdings going public. By Stephen Taub November 24, 2020
